Top 10 Oncology Intermediates Shaping the Future of Cancer Treatment in 2025
A concise overview of the top 10 oncology intermediates expected to drive cancer therapy innovation in 2025, including PROTAC, ADC linkers, PARP cores, and radiopharmaceutical chelators.










